Yu-chi Chen
State Key Laboratory Of Quality Research In Chinese Medicine
Macao, 999078, China
Macao, 999078, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer.
Journal: Frontiers of medicine
Published: December 30, 2021
Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells.
Journal: Biochemical pharmacology
Published: November 19, 2021
Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies.
Journal: Current cancer drug targets
Published: September 08, 2021
Regulation of CD47 expression by interferon-gamma in cancer cells.
Journal: Translational oncology
Published: April 20, 2021
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective.
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective.
Journal: Journal of cancer research and clinical oncology
Published: March 17, 2021
Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 30, 2020
Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells.
Journal: Chinese journal of natural medicines
Published: December 28, 2019
Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: December 24, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026